Biotechnology

Jyong Biotech

Jyong Biotech Completes Four Phase III Clinical Trials for Drug MCS-2

Jyong Biotech released FY2025 Q1 earnings on January 9 (EST), actual revenue USD 0, actual EPS USD -0.01

Jyong Biotech released FY2025 Semi-Annual Earnings on January 9, 2026 (EST), with actual revenue of USD 0 and EPS of USD -0.0174

Jyong Biotech released FY2025 Q2 earnings on January 9 (EST), actual revenue USD 0, actual EPS USD -0.0087

Jyong Biotech Ltd Negotiates with Investment Funds for Stock Purchase

Jyong Biotech Stock Hits 52-Week Low

Jyong Biotech Completes Phase II Clinical Trial of MCS-8

Jyong Biotech Ltd. released FY2024 Annual Earnings on April 23 Post-Market (EST), actual revenue USD 0, actual EPS USD -0.0421

Jyong Biotech Ltd. released FY2023 9 Months Earnings on April 23, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.0429

Jyong Biotech Ltd. released FY2024 Q3 earnings on April 23, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.0118

Jyong Biotech Ltd. released FY2023 Annual Earnings on April 23, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.0614

Jyong Biotech Ltd. released FY2023 Q3 earnings on April 23 (EST), actual revenue USD 0, actual EPS USD -0.0185

Jyong Biotech Ltd. released FY2024 Q4 earnings on April 23 Post-Market (EST), actual revenue USD 0, actual EPS USD -0.0118

Jyong Biotech Ltd. released FY2023 Q4 earnings on April 23, 2025 (EST), with actual revenue of USD 0 and EPS of USD -0.0185

Jyong Biotech Ltd. released FY2024 9 Months earnings on April 23 Post-Market (EST), actual revenue USD 0, actual EPS USD -0.0303

Jyong Biotech Ltd. released FY2024 Q2 earnings on October 4 (EST) with actual revenue of USD 0 and EPS of USD -0.0092

Jyong Biotech Ltd. released FY2023 Semi-Annual Earnings on October 4, 2024 (EST) with actual revenue of USD 0 and EPS of USD -0.0243

Jyong Biotech Ltd. released FY2023 Q1 earnings on October 4, 2024 (EST) with actual revenue of USD 0 and EPS of USD -0.0121

Jyong Biotech Ltd. released FY2024 Semi-Annual earnings on October 4, 2024 (EST) with actual revenue USD 0 and EPS USD -0.0185

Jyong Biotech Ltd. released FY2024 Q1 earnings on October 4, 2024 (EST) with actual revenue of USD 0 and EPS of USD -0.0092

U Power

Neuberger Berman Income Funds - Neuberger High Yield Strategies Fund Inc.

Beasley Broadcast

Hub Cyber Security

XCF Global

The Gabelli Equity Trust Inc.

Sleep Number

Mega Fortune

Click Holdings/BVI

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

Jyong Biotech(MENS.US)

Jyong Biotech Stock Performance Chart